CHLORDIAZEPOXIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Chlordiazepoxide, and what generic alternatives are available?
Chlordiazepoxide is a drug marketed by Chartwell Rx, Heritage Pharma, Micro Labs, Mylan Pharms Inc, Tp Anda Holdings, Usl Pharma, Ascot, Barr, Ferrante, Halsey, Impax Labs, Ivax Sub Teva Pharms, Lederle, Mast Mm, Mylan, Parke Davis, Pioneer Pharms, Purepac Pharm, Roxane, Superpharm, Teva, Upsher Smith Labs, Vangard, Watson Labs, West Ward, Alembic, Alkem Labs Ltd, Amneal, Aurobindo Pharma Ltd, Corepharma, Dr Reddys, Misemer, Nuvo Pharms Inc, Teva Pharms Usa, Torrent, and Winder Labs Llc. and is included in eighty-seven NDAs.
The generic ingredient in CHLORDIAZEPOXIDE is chlordiazepoxide hydrochloride; clidinium bromide. There are nine drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the chlordiazepoxide hydrochloride; clidinium bromide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Chlordiazepoxide
A generic version of CHLORDIAZEPOXIDE was approved as chlordiazepoxide hydrochloride; clidinium bromide by NUVO PHARMS INC on July 7th, 2020.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CHLORDIAZEPOXIDE?
- What are the global sales for CHLORDIAZEPOXIDE?
- What is Average Wholesale Price for CHLORDIAZEPOXIDE?
Summary for CHLORDIAZEPOXIDE
| US Patents: | 0 |
| Applicants: | 36 |
| NDAs: | 87 |
| Drug Prices: | Drug price information for CHLORDIAZEPOXIDE |
| DailyMed Link: | CHLORDIAZEPOXIDE at DailyMed |
Recent Clinical Trials for CHLORDIAZEPOXIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Mayo Clinic | Phase 4 |
| Oregon Health and Science University | Phase 2 |
| Taipei City Hospital | Phase 2/Phase 3 |
Medical Subject Heading (MeSH) Categories for CHLORDIAZEPOXIDE
Anatomical Therapeutic Chemical (ATC) Classes for CHLORDIAZEPOXIDE
US Patents and Regulatory Information for CHLORDIAZEPOXIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | CHLORDIAZEPOXIDE HYDROCHLORIDE | chlordiazepoxide hydrochloride | CAPSULE;ORAL | 086294-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Mylan | CHLORDIAZEPOXIDE HYDROCHLORIDE | chlordiazepoxide hydrochloride | CAPSULE;ORAL | 084886-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ivax Sub Teva Pharms | CHLORDIAZEPOXIDE HYDROCHLORIDE | chlordiazepoxide hydrochloride | CAPSULE;ORAL | 083742-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
